Adagene Inc. announced that Ms. Chunfang (Vicky) Gu resigned from her position as Executive Director of Finance effective September 30, 2026, citing personal reasons. The company confirmed there are no disagreements with the Board and no matters requiring shareholder attention regarding this departure. Adagene Inc. operates in the biotechnology industry, focusing on the discovery and development of novel immunotherapies for cancer.
